Omkar Speciality files patent for preparation of Cardiovascular drug

09 Mar 2018 Evaluate

Omkar Speciality Chemicals has applied for grant of patent for ‘Process for preparation of Cardiovascular drug key intermediate 2-butyl-3-(3,5-diiodo-4-hydroxybenzoyl) benzofuran’. This intermediate has been developed for first time in India. Till date, all supplies were from foreign markets. The company is pioneer in developing and supplying this intermediate with finest quality.

Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.


Omkar SpecialityChem Share Price

5.62 0.25 (4.66%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3898.35
Tata Chemicals 756.25
SRF 3014.30
Pidilite Inds. 1472.25
Deepak Nitrite 1597.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×